A bromine analogue of picoplatin: a new substance from the group of platinum-based chemotherapeutics

被引:3
|
作者
Pazout, Richard [1 ]
Maixner, Jaroslav [1 ]
Hrda, Michaela [2 ]
Louzilova, Tereza [2 ]
Kacer, Petr [2 ]
机构
[1] Inst Chem Technol, Cent Labs, CR-16628 Prague, Czech Republic
[2] Inst Chem Technol, Dept Organ Technol, CR-16628 Prague, Czech Republic
关键词
Molecules - Bromine - Chains - Platinum compounds;
D O I
10.1107/S0108270113004708
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A new substance, cis-amminedibromido(2-methylpyridine-N)platinum(II), cis-[PtBr2(C6H7N)(NH3)], which is a potential platinum-based antineoplastic agent for the treatment of patients with solid tumors, has been synthesized and structurally characterized. There is one molecule in the asymmetric unit and molecules are linked via two symmetry-independent NH...Br hydrogen bonds into zigzag chains running parallel to the c axis. CH...Br hydrogen bonds crosslink these chains to give a layer parallel to (010). NH...Br hydrogen bonds and stacking interactions between pairs of pyridine rings stack the layers along b.
引用
收藏
页码:337 / +
页数:7
相关论文
共 50 条
  • [1] CARBON NANOTUBES AS CONTAINERS FOR PLATINUM-BASED CHEMOTHERAPEUTICS
    Kraemer, Kai
    Arlt, Marcus
    Silke, Hampel
    Haase, Diana
    Fuessel, Susanne
    Schulze, Renate
    Leonhardt, Albrecht
    Wirth, Manfred P.
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E462 - E462
  • [2] Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics
    Hato, Stanleyson V.
    Andrea Khong
    de Vries, I. Jolanda M.
    Lesterhuis, W. Joost
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (11) : 2831 - 2837
  • [3] Intralymphatic delivery of platinum-based chemotherapeutics is possible: an experimental study
    Zor, Murat
    Yildirim, Ibrahim
    Basal, Seref
    Yaman, Halil
    Ozturk, Mustafa
    Irkilata, Cem Hasan
    Goktas, Serdar
    Dayanc, Murat
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (10) : 1679 - 1682
  • [4] Intralymphatic delivery of platinum-based chemotherapeutics is possible: an experimental study
    Murat Zor
    Ibrahim Yildirim
    Seref Basal
    Halil Yaman
    Mustafa Ozturk
    Cem Hasan Irkilata
    Serdar Goktas
    Murat Dayanc
    [J]. Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1679 - 1682
  • [5] Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
    Schoch, Sarah
    Gajewski, Sabine
    Rothfuss, Jana
    Hartwig, Andrea
    Koberle, Beate
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 20
  • [6] Combination therapy: Histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer
    Diyabalanage, Himashinie V. K.
    Granda, Michael L.
    Hooker, Jacob M.
    [J]. CANCER LETTERS, 2013, 329 (01) : 1 - 8
  • [7] Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action
    Khoury, Aleen
    Deo, Krishant M.
    Aldrich-Wright, Janice R.
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2020, 207
  • [8] Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics-A Review
    Stankovic, Jelena S. Katanic
    Selakovic, Dragica
    Mihailovic, Vladimir
    Rosic, Gvozden
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 28
  • [9] The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics
    Pan, Zhenrui
    Zhang, Hanxiao
    Dokudovskaya, Svetlana
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [10] The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC
    Wang, Ya-Di
    Ha, Min-Wen
    Cheng, Jian
    Zhang, Wen-Lu
    Cong, Xue
    Tong, Chun-Yan
    Sun, Jing
    [J]. ONCOLOGY REPORTS, 2012, 27 (04) : 979 - 986